Updated: Two More Stelara Biosimilars Launch, Including One that is 90% Off Stelara

Sandoz and Biocon Biologics have each launched their biosimilar versions of Johnson & Johnson’s Stelara (ustekinumab).Pyzchiva (ustekinumab-ttwe), developed by Samsung Bioepis and commercialized b